Pharmerica (PMC) Tops Q3 EPS by 3c

Pharmerica (NYSE: PMC) reported Q3 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $498.8 million versus the consensus estimate of $480.35 million.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Schwab's May activity shows margin loans nearly double
• Medtronic completes $550 million Scientia Vascular acquisition